Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Randomized, Open-label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients

NCT02174731 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02174731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02174731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Randomized, Open-label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2014
Completion date
September 26, 2018
Enrollment
2,133 (actual)
Sites
188

Conditions

As the registry lists them; a condition with its own page is linked.

anemia